Porton Pharma Solutions Ltd. (300363)
Market Open
11 Aug, 06:57
XSHE XSHE Primary ¥
21. 94
+0.29
+1.3395%
¥
12.81B Market Cap
- P/E Ratio
1.95% Div Yield
21.72M Volume
- Eps
¥ 21.65
Previous Close Want to track 300363 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | 0.1 |
| | | - | 0.06 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.08 |
| | | - | 0.07 |
| | | - | 0.11 |
| | | - | 0.11 |
| | | - | 0.06 |
| | | - | 0.07 |
| | | - | 0.06 |
| | | - | 0.08 |
| | | - | 0.14 |
| | | - | 0.06 |
| | | - | 0.03 |
300363 Earnings Reports FAQ
What is the earnings per share (EPS) for 300363?
EPS data for 300363 is currently not available, as Porton Pharma Solutions Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 10.85%, reflecting the 300363's performance and XSHE market conditions.
When is the next earnings release date?
Porton Pharma Solutions Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Porton Pharma Solutions Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 300363 at this time, as Porton Pharma Solutions Ltd has no recent EPS data to calculate it.
